Canada markets close in 28 minutes

CERo Therapeutics Holdings, Inc. (CERO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.1450+0.0150 (+1.33%)
As of 02:51PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
Total Revenue
0
0
0
Operating Expenses
Research Development
8,849
9,846
9,137
Selling General and Administrative
2,028
2,126
2,479
Total Operating Expenses
10,877
11,971
11,616
Operating Income or Loss
-10,877
-11,971
-11,616
Income Before Tax
-10,752
-11,829
-10,630
Income from Continuing Operations
-10,752
-11,829
-10,630
Net Income
-10,752
-11,829
-10,630
Net Income available to common shareholders
-10,752
-11,829
-10,630
Basic EPS
-1.04
-1.15
-1.03
Diluted EPS
-1.04
-1.15
-1.03
Basic Average Shares
10,293
10,293
10,293
Diluted Average Shares
10,293
10,293
10,293